<DOC>
	<DOCNO>NCT01589133</DOCNO>
	<brief_summary>The purpose study assess consistency result irregular antibody screen Surgiscreen （investigational reagent ) Serascan Diana 3 ( control reagent ) , consistency result irregular antibody screen investigational reagent serum plasma patient .</brief_summary>
	<brief_title>Surgiscreen Registration</brief_title>
	<detailed_description />
	<criteria>Serum plasma sample leave routine clinical testing ; Blood sample day , blood sample store 28°C 3 day collection , serum plasma sample store 20°C separate 3 day collection . Samples severe hemolysis , jaundice chylelike sample ; Small sample size insufficient complete testing ; Samples collect process upon requirement instruction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Irregular antibody screen</keyword>
</DOC>